Vascular smooth muscle cell migration induced by domains of thrombospondin-1 is differentially regulated.

[1]  V. Gahtan,et al.  Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis. , 2011, The Journal of surgical research.

[2]  V. Gahtan,et al.  Thrombospondin 1, Fibronectin, and Vitronectin are Differentially Dependent Upon RAS, ERK1/2, and p38 for Induction of Vascular Smooth Muscle Cell Chemotaxis , 2011, Vascular and endovascular surgery.

[3]  V. Gahtan,et al.  Thrombospondin-1-induced vascular smooth muscle cell migration is dependent on the hyaluronic acid receptor CD44. , 2009, American journal of surgery.

[4]  W. Xiong,et al.  Thrombospondin Induces RhoA Inactivation through FAK-dependent Signaling to Stimulate Focal Adhesion Disassembly* , 2004, Journal of Biological Chemistry.

[5]  V. Gahtan,et al.  Thrombospondin‐1‐induced vascular smooth muscle cell chemotaxis: The role of the type 3 repeat and carboxyl terminal domains , 2003, Journal of cellular biochemistry.

[6]  J. Lawler,et al.  Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms. , 2001, Cancer research.

[7]  V. Gahtan,et al.  The C-terminal domain of thrombospondin-1 induces vascular smooth muscle cell chemotaxis. , 2001, Journal of vascular surgery.

[8]  A. Hughes,et al.  Phosphatidylinositol 3-kinase and focal adhesion kinase are early signals in the growth factor-like responses to thrombospondin-1 seen in human vascular smooth muscle. , 1999, Arteriosclerosis, thrombosis, and vascular biology.